These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5389145)

  • 1. The synthesis and some pharmacological activities of[4-L-norvaline]-oxytocin and [4-L-norleucine]-oxytocin and their deamino analogs.
    Flouret G; Du Vigneaud V
    J Med Chem; 1969 Nov; 12(6):1035-8. PubMed ID: 5389145
    [No Abstract]   [Full Text] [Related]  

  • 2. [Synthesis and some pharmacological activities of [2-L-valine]-oxytocin and [2-L-leucine]-oxytocin.
    Hruby VJ; Du Vigneaud V
    J Med Chem; 1969 Sep; 12(5):731-3. PubMed ID: 5818088
    [No Abstract]   [Full Text] [Related]  

  • 3. Crystalline deamino-dicarba-oxytocin. Preparation and some pharmacological properties.
    Yamanaka T; Hase S; Sakakibara S; Schwartz IL; Dubois BM; Walter R
    Mol Pharmacol; 1970 Sep; 6(5):474-80. PubMed ID: 5466703
    [No Abstract]   [Full Text] [Related]  

  • 4. The synthesis of (1-deamino,4-L-leucine)-oxytocin and (1-deamino,4-L-isoleucine)-oxytocin and some of their pharmacological properties.
    Takashima H; Hruby VJ; Du Vigneaud V
    J Am Chem Soc; 1970 Feb; 92(3):677-80. PubMed ID: 5460748
    [No Abstract]   [Full Text] [Related]  

  • 5. 4-Threonine analogues of neurohypophysial hormones withh selectively enhanced oxytocin-like activities.
    Sawyer WH; Manning M
    J Endocrinol; 1971 Jan; 49(1):151-65. PubMed ID: 5104449
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of an amide group in place of the disulfide bridge in deamino-oxytocin.
    Hase S; Sakakibara S; Wahrenburg M; Walter R
    J Med Chem; 1972 Oct; 15(10):1017-9. PubMed ID: 4672192
    [No Abstract]   [Full Text] [Related]  

  • 7. Syntheses and pharmacological properties of selenium isologs of oxytocin and deamino-oxytocin.
    Walter R; Chan WY
    J Am Chem Soc; 1967 Jul; 89(15):3892-8. PubMed ID: 6068786
    [No Abstract]   [Full Text] [Related]  

  • 8. The synthesis and some of the pharmacological properties of [4-L-isoleucine]-oxytocin and [4-L-leucine]-oxytocin.
    Hruby VJ; Flouret G; du Vigneaud V
    J Biol Chem; 1969 Jul; 244(14):3890-4. PubMed ID: 5817165
    [No Abstract]   [Full Text] [Related]  

  • 9. Solid-phase synthesis of (4-threonine)-oxytocin. A more potent and specific oxytocic agent than oxytocin.
    Manning M; Coy E; Sawyer WH
    Biochemistry; 1970 Sep; 9(20):3925-30. PubMed ID: 5533681
    [No Abstract]   [Full Text] [Related]  

  • 10. Solid-phase syntheis and some pharmacological properties of [8-phenylalanine]-oxytocin.
    Baxter JW; Manning M; Sawyer WH
    Biochemistry; 1969 Sep; 8(9):3592-7. PubMed ID: 5387525
    [No Abstract]   [Full Text] [Related]  

  • 11. Glutamine isomers of oxytocin and deamino-oxytocin: synthesis and pharmacological properties of [4-N4-methyl-L-asparagine]-oxytocin and [1-beta-mercaptopropionic acid, 4-N4-methyl-L-asparagine]-oxytocin.
    Havran RT; Schwartz IL; Walter R
    Mol Pharmacol; 1969 Jan; 5(1):83-9. PubMed ID: 5373890
    [No Abstract]   [Full Text] [Related]  

  • 12. Study of pituitary hormone analogs for their inhibitory properties and resistance to carboxamidopeptidases: (9-L-proline)oxytocin, (9-L-glutamic acid)oxytocin, and (8-L-lysine,9-glycine methylamide)oxytocin.
    Grzonka Z; Glass JD; Schwartz IL; Walter R
    J Med Chem; 1974 Dec; 17(12):1294-8. PubMed ID: 4427327
    [No Abstract]   [Full Text] [Related]  

  • 13. Solid phase synthesis of (3,4-dileucine)-oxytocin and a study of some of its pharmacological properties.
    Wille MA; Cahn WY; Du Vigneaud V
    J Med Chem; 1972 Jan; 15(1):11-2. PubMed ID: 5061981
    [No Abstract]   [Full Text] [Related]  

  • 14. Solid-phase synthesis of (2-isoleucine, 4-leucine) oxytocin and (2-phenylalanine, 4-leucine) oxytocin and some their pharmacological properties.
    Hruby VJ; Muscio F; Gronginsky CM; Gitu PM; Saba D; Chan WY
    J Med Chem; 1973 Jun; 16(6):624-9. PubMed ID: 4733119
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacology of cyclic analogues of deamino-oxytocin not containing a disulphide bond (carba analogues).
    Barth T; Krejcí I; Kupková B; Jost K
    Eur J Pharmacol; 1973 Nov; 24(2):183-8. PubMed ID: 4797285
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined high oxytocic with negligible antidiuretic and pressor activities in multisubstituted oxytocins.
    Stahl GL; Walter R
    J Med Chem; 1977 Apr; 20(4):492-5. PubMed ID: 850233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic analogues of oxytocin acting as hormonogens.
    Beránková-Ksandrová Z; Bisset GW; Jost K; Krejci I; Pliska V; Rudinger J; Rychlík I; Sorm F
    Br J Pharmacol Chemother; 1966 Mar; 26(3):615-32. PubMed ID: 6006301
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and some pharmacological properties of [4-threonine,7-sarcosine]oxytocin, a peptide with high oxytocic potency, and of [4-threonine,7-N-methylalanine]oxytocin.
    Grzonka Z; Lammek B; Gazis D; Schwartz IL
    J Med Chem; 1983 Dec; 26(12):1786-7. PubMed ID: 6685771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synthesis and some pharmacological properties of (2-L-DOPA)-oxytocin.
    Ferrier BM; Branda LA
    Can J Biochem; 1976 May; 54(5):507-11. PubMed ID: 1276975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and pharmacological properties of [1-L-penicillamine,4-L-leucine]oxytocin.
    Ferger MF; Chan WY
    J Med Chem; 1975 Oct; 18(10):1020-2. PubMed ID: 1159679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.